These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 8225601

  • 1. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM, Michetti P, Winner LS, Mack JA, Mekalanos JJ, Neutra MR.
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [Abstract] [Full Text] [Related]

  • 2. Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro.
    Apter FM, Lencer WI, Finkelstein RA, Mekalanos JJ, Neutra MR.
    Infect Immun; 1993 Dec; 61(12):5271-8. PubMed ID: 7693598
    [Abstract] [Full Text] [Related]

  • 3. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.
    Winner L, Mack J, Weltzin R, Mekalanos JJ, Kraehenbuhl JP, Neutra MR.
    Infect Immun; 1991 Mar; 59(3):977-82. PubMed ID: 1705246
    [Abstract] [Full Text] [Related]

  • 4. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M, Chaicumpa W, Kalambaheti T, Surachedchai Y, Thanungkul B.
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [Abstract] [Full Text] [Related]

  • 5. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D, Yuki Y, Nochi T, Kodama T, Mejima M, Kurokawa S, Takahashi Y, Nanno M, Nakanishi U, Takaiwa F, Honda T, Kiyono H.
    Proc Natl Acad Sci U S A; 2010 May 11; 107(19):8794-9. PubMed ID: 20421480
    [Abstract] [Full Text] [Related]

  • 6. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J, Gibson JA, Pickering BS, Watnick PI.
    mSphere; 2018 Jun 27; 3(3):. PubMed ID: 29875145
    [Abstract] [Full Text] [Related]

  • 7. Distribution of monoclonal antibodies in intestinal and urogenital secretions of mice bearing hybridoma 'backpack' tumours.
    Haneberg B, Kendall D, Apter FM, Neutra MR.
    Scand J Immunol; 1997 Feb 27; 45(2):151-9. PubMed ID: 9042427
    [Abstract] [Full Text] [Related]

  • 8. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME, Brero ML, Mateo NA.
    Microbiol Immunol; 2006 Feb 27; 50(8):607-19. PubMed ID: 16924145
    [Abstract] [Full Text] [Related]

  • 9. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ, De Jesus M, Mantis NJ.
    Infect Immun; 2015 Apr 27; 83(4):1674-83. PubMed ID: 25667263
    [Abstract] [Full Text] [Related]

  • 10. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
    Qadri F, Ahmed F, Karim MM, Wenneras C, Begum YA, Abdus Salam M, Albert MJ, McGhee JR.
    Clin Diagn Lab Immunol; 1999 Nov 27; 6(6):812-8. PubMed ID: 10548569
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.
    Price GA, Holmes RK.
    PLoS One; 2012 Nov 27; 7(8):e42434. PubMed ID: 22879984
    [Abstract] [Full Text] [Related]

  • 12. Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice.
    Lee CK, Weltzin R, Soman G, Georgakopoulos KM, Houle DM, Monath TP.
    Infect Immun; 1994 Mar 27; 62(3):887-91. PubMed ID: 8112859
    [Abstract] [Full Text] [Related]

  • 13. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.
    Vaccine; 2011 Oct 06; 29(43):7505-13. PubMed ID: 21807059
    [Abstract] [Full Text] [Related]

  • 14. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
    Kauffman RC, Bhuiyan TR, Nakajima R, Mayo-Smith LM, Rashu R, Hoq MR, Chowdhury F, Khan AI, Rahman A, Bhaumik SK, Harris L, O'Neal JT, Trost JF, Alam NH, Jasinskas A, Dotsey E, Kelly M, Charles RC, Xu P, Kováč P, Calderwood SB, Ryan ET, Felgner PL, Qadri F, Wrammert J, Harris JB.
    mBio; 2016 Dec 20; 7(6):. PubMed ID: 27999163
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
    Baranova DE, Willsey GG, Levinson KJ, Smith C, Wade J, Mantis NJ.
    Pathog Dis; 2020 Jun 01; 78(4):. PubMed ID: 32589220
    [Abstract] [Full Text] [Related]

  • 16. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
    Losonsky GA, Tacket CO, Wasserman SS, Kaper JB, Levine MM.
    Infect Immun; 1993 Feb 01; 61(2):729-33. PubMed ID: 8423098
    [Abstract] [Full Text] [Related]

  • 17. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
    Ryan ET, Butterton JR, Zhang T, Baker MA, Stanley SL, Calderwood SB.
    Infect Immun; 1997 Aug 01; 65(8):3118-25. PubMed ID: 9234763
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination.
    Rijpkema SG, Jansen WH, Gielen H, Guinée PA.
    Microb Pathog; 1987 Nov 01; 3(5):365-75. PubMed ID: 2462153
    [Abstract] [Full Text] [Related]

  • 19. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
    Walia K, Vohra H, Singh H, Ganguly NK.
    Microbiol Immunol; 2000 Nov 01; 44(11):931-40. PubMed ID: 11145274
    [Abstract] [Full Text] [Related]

  • 20. Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera.
    Osek J, Jonson G, Svennerholm AM, Holmgren J.
    Infect Immun; 1994 Jul 01; 62(7):2901-7. PubMed ID: 7911787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.